Ligand Design, Synthesis and Biological Anti-HCV Evaluations for Genotypes 1b and 4a of Certain 4-(3- & 4-[3-(3,5-Dibromo-4-Hydroxyphenyl)-Propylamino]phenyl) Butyric Acids and 3-(3,5-Dibromo-4-Hydroxyphenyl)-Propylamino-Acetamidobenzoic Acid Esters
Journal of Enzyme Inhibition and Medicinal Chemistry - United Kingdom
doi 10.3109/14756366.2012.733384
Full Text
Open PDFAbstract
Available in full text
Date
January 7, 2013
Authors
Publisher
Informa UK Limited